Company page
Hamlet Biopharma Ab Class B
Hamlet Biopharma Ab Class B, traded under the ticker HAMLET.B, is a public company based in Sweden with a market capitalization of approximately 108.4 million SEK. The company focuses on developing innovative treatments in the biopharmaceutical sector. Its operations are centered around advancing therapies that target cancer and other serious diseases.
- Ticker
- HAMLET.B:NGM
- Asset type
- Stock
- Market cap
- $108.4M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NGM
- Currency
- SEK